Cytokine actions in the central nervous system

Cytokine and Growth Factor Reviews

Volumn 9, Issue 3-4, 1998, Pages 259-275

  Benveniste, Etty N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Cytokines; Glial Cells; Multiple Sclerosis; Neurons; Receptors

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ALZHEIMER DISEASE; ANIMAL; CENTRAL NERVOUS SYSTEM; CYTOKINE PRODUCTION; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; INFLAMMATION; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PATHOLOGY; PHYSIOLOGY; REVIEW; STROKE;

ANIMALS; CENTRAL NERVOUS SYSTEM; CYTOKINES; HUMANS; IMMUNE SYSTEM; INFLAMMATION;

EID: 0345580623     PISSN: 13596101     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6101(98)00015-X     Document Type: Review

References (199)

1. Baker CF, Billingham RF. Immunologically privileged sites. Adv Immunol 1977, 25, 1-49.
2. Nathanson JA, Chun LLY. Immunological function of the blood-cerebrospinal fluid barrier. Proc Natl Acad Sci USA 1989, 86, 1684-1688.
3. Shrikant P, Benveniste EN. The central nervous system as an immunocompetent organ: role of glial cells in antigen presentation. J Immunol 1996, 157, 1819-1822.
4. Hickey WF, Hsu BL, Kimura H. T-lymphocyte entry into the central nervous system. J Neurosci Res 1991, 28, 254-260.
5. Benveniste EN. Cytokines: Influence on glial cell gene expression and function. In Blalock JE, ed. Neuroimmunoendocrinology, Karger, Basel, 1997: 31-75.
6. Hatten ME, Liem RKH, Shelanski ML, Mason CA. Astroglia in CNS injury. GLIA 1991, 4, 233-243.
7. Hickey WF, Kimura H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988, 239, 290-292.
8. Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci 1996, 19, 312-318.
9. Benveniste EN. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med 1997, 75, 165-173.
10. Pfeiffer SE, Warrington AE, Bansal R. The oligodendrocyte and its many cellular processes. Trends Cell Biol 1993, 3, 191-197.
11. Billiau A. Interferon-γ: biology and role in pathogenesis. In Advances in Immunology. Academic Press, Inc., 1996: 61-130.
12. Rohn WM, Lee Y-J, Benveniste EN. Regulation of class II MHC expression. Crit Rev Immunol 1996, 16, 311-330.
13. Farrar MA, Schreiber RD. The molecular cell biology of interferon-γ and its receptor. Annu Rev Immunol 1993, 11, 571-611.
14. Darnell JE, Jr. STATs and gene regulation. Science 1997, 277, 1630-1635.
15. Hofman FM, VonHanwher R, Dinarello C, Mizel S, Hinton D, Merrill JE. Immunoregulatory molecules and IL-2 receptors identified in multiple sclerosis brain. J Immunol 1986, 136, 3239-3245.
16. Traugott U, Lebon P. Interferon-γ and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions. J Neurol Sci 1988, 84, 257-264.
17. Cannella B, Raine CS. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995, 37, 424-435.
18. Olsson T, Kelic S, Edlund C, Bakhiet M., Höjeberg B, van der Meide PH, Lungdahl A, Kristensson K. Neuronal interferon-γ immunoreactive molecule: bioactivities and purification. Eur J Immunol 1994, 24, 308-314.
19. Kiefer R, Kreutzberg GW. Gamma interferon-like immunoreactivity in the rat nervous system. Neurosci 1990, 37, 725-734.
20. Neumann H, Schmidt H, Wilharm E, Behrens L, Wekerle H. Interferon γ gene expression in sensory neurons: evidence for autocrine gene regulation. J Exp Med 1997, 186, 2023-2031.
21. Schmidt B, Stoll G, Toyka KV, Hartung H-P. Rat astrocytes express interferon-γ immunoreactivity in normal optic nerve and after nerve transaction. Brain Res 1990, 515, 347-350.
22. De Simone R, Levi G, Aloisi F. Interferon-γ gene expression in rat central nervous system glial cells. Cytokine 1998, 10, 418-422.
23. Yong VW, Moumdjian R, Yong FP, Ruijs TCG, Freedman MS, Cashman N, Antel JP. γ-interferon promotes proliferation of adult human astrocytes in vitro and reactive gliosis in the adult mouse brain in vivo. Proc Natl Acad Sci USA 1991, 88, 7016-7020.
24. Balasingam V, Tejada-Berges T, Wright E, Bouckova R, Yong VW. Reactive astrogliosis in the neonatal mouse brain and its modulation by cytokines. J Neurosci 1994, 14, 846-856.
25. Corbin JG, Kelly D, Rath EM, Baerwald KD, Suzuki K, Popko B. Targeted CNS expression of interferon-gamma in transgenic mice leads to hypomyelination, reactive gliosis, and abnormal cerebellar development. Mol Cell Neurosci 1996, 7, 354-370.
26. Rostworowski M, Balasingam V, Chabot S, Owens T, Yong VW. Astrogliosis in the neonatal and adult murine brain post-trauma: elevation of inflammatory cytokines and the lack of requirement for endogenous interferon-γ. J Neurosci 1997, 17, 3664-3674.
27. June CH, Bluestone JA., Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994, 15, 321-331.
28. Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol 1998, 16, 111-135.
29. Fontana A, Fierz W, Wekerle H. Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 1984, 307, 273-276.
30. Wong GHW, Bartlett PF, Clark-Lewis I, Battye F, Schrader JW. Inducible expression of H-2 and Ia antigens on brain cells. Nature 1984, 310, 688-691.
31. Vidovic M., Sparacio SM, Elovitz M, Benveniste EN. Induction and regulation of class II MHC mRNA expression in astrocytes by IFN-γ and TNF-α. J Neuroimmunol 1990, 30, 189-200.
32. Frohman EM, Frohman TC, Dustin ML, Vayuvegula B, Choi B, Gupta A, van den Noort S, Gupta S. The induction of intercellular adhesion molecule -1 (ICAM-1) expression on human fetal astrocytes by interferon-γ, tumor necrosis factor-α, lymphotoxin, and interleukin-1: relevance to intracerebral antigen presentation. J Neuroimmunol 1989, 23, 117-124.
33. Rosenman SJ, Shrikant P, Dubb L, Benveniste EN, Ransohoff RM. Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. J Immunol 1995, 154, 1888-1899.
34. Shrikant P, Weber E, Jilling T, Benveniste EN. ICAM-1 gene expression by glial cells: differential mechanisms of inhibition by interleukin-10 and interleukin-6. J Immunol 1995, 155, 1489-1501.
35. Winkler M, Benveniste EN. Transforming growth factor-beta inhibition of cytokine-induced vascular cell adhesion molecule-1 expression in human astrocytes. GLIA 1998, 22, 171-179.
36. Vass K, Lassmann H. Intrathecal application of interferon gamma. Amer J Path 1990, 137, 789-800.
37. Lee SC, Moore GRW, Golenwsky G, Raine CS. Multiple sclerosis: A role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study. J Neuropathol Exp Neurol 1990, 49, 122-136.
38. Hickey WF, Osborn JP, Kirby WM. Expression of Ia molecules by astrocytes during acute experimental allergic encephalomyelitis in the Lewis rat. Cell Immunol 1985, 91, 528-535.
39. Matsumoto Y, Kawai K, Fujiwara M. In situ Ia expression on brain cells in the rat: Autoimmune encephalomyelitis-resistant strain (BN) and susceptible strain (Lewis) compared. Immunol 1989, 66, 621-627.
40. Satoh J-I, Lee YB, Kim SU. T-cell costimulatory molecules B7-1 (CD80) and B7-2 (CD86) are expressed in human microglia but not in astrocytes in culture. Brain Res 1995, 704, 92-96.
41. Aloisi F, Ria F, Penna G, Adorini L. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J Immunol 1998, 160, 4671-4680.
42. Nikcevich KM, Gordon KB, Tan L, Hurst SD, Kroepfl JF, Gardinier M, Barrett TA, Miller SD. INF-γ-activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J Immunol 1997, 158, 614-621.
43. Tan L, Gordon KB, Mueller JP, Matis LA, Miller SD. Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-γ-activated SJL/J astrocytes. J Immunol 1998, 160, 4271-4279.
44. Issazadeh S, Navikas V, Schaub M, Sayegh M, Khoury S. Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J Immunol 1998, 161, 1104-1112.
45. Fierz W, Endler B, Reske K., Wekerle H, Fontana A. Astrocytes as antigen presenting cells. I. Induction of Ia antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J Immunol 1985, 134, 3785-3793.
46. Matsumoto Y, Ohmori K, Fujiwara M. Immune regulation by brain cells in the central nervous system: microglia but not astrocytes present myelin basic protein to encephalitogenic T cells under in vivo-mimicking conditions. Immunol 1992, 76, 209-216.
47. Weber F, Meinl E, Aloisi F, Nevinny-Stickel C, Albert E, Wekerle H, Hohlfeld R. Human astrocytes are only partially competent antigen presenting cells. Brain 1994, 117, 59-69.
48. + T cell responses in the central nervous system. J Exp Med 1991, 173, 1235-1246.
49. Williams KC, Dooley NP, Ulvestad E, Waage A, Blain M, Yong VW, Antel JP. Antigen presentation by human fetal astrocytes with the cooperative effect of microglia or the microglial-derived cytokine IL-1. J Neurosci 1995, 15, 1869-1878.
50. Gold R, Schmied M, Tontsch U, Hartung HP, Wekerle H, Toyka KV, Lassmann H. Antigen presentation by astrocytes primes rat T lymphocytes for apoptotic cell death. Brain 1996, 119, 651-659.
51. Lee Y-J, Han Y, Lu H-T, Nguyen V, Qin H, Howe PH, Hocevar BA, Boss JM, Ransohoff RM, Benveniste EN. TGF-β suppresses IFN-γ induction of class II MHC gene expression by inhibiting class II transactivator messenger RNA expression. J Immunol 1997, 158, 2065-2075.
52. Rohn W, Tang LP, Dong Y, Benveniste EN. IL-1β inhibits IFN-γ induced class II MHC expression by suppressing transcription of the class II transactivator gene. J Immunol 1998, (In press).
53. Tontsch U, Rott O. Cortical neurons selectively inhibit MHC class II induction in astrocytes but not in microglial cells. Inter Immunol 1993, 5, 249-254.
54. Neumann H, Boucraut J, Hahnel C, Misgeld T, Wekerle H. Neuronal control of MHC class II inducibility in rat astrocytes and microglia. Eur J Neurosci 1996, 8, 2582-2590.
55. Neumann H, Wekerle H. Neuronal control of the immune response in the central nervous system: linking brain immunity to neurodegeneration. J Neuropathol Exp Neurol 1998, 57, 1-9.
56. Shrikant P, Chung IY, Ballestas M, Benveniste EN. Regulation of intercellular adhesion molecule-1 gene expression by tumor necrosis factor-α, interleukin-1β, and interferon-γ in astrocytes. J Neuroimmunol 1994, 51, 209-220.
57. Lee SJ, Park JY, Hou J, Benveniste EN. Transcriptional regulation of the intercellular adhesion molecule-1 gene by proinflammatory cytokines in human astrocytes. GLIA 1998, (In press).
58. Héry C, Sébire G, Peudenier S, Tardieu M. Adhesion to human neurons and astrocytes of monocytes: the role of interaction of CR3 and ICAM-1 and modulation by cytokines. J Neuroimmunol 1995, 57, 101-109.
59. Frei K, Siepl C, Groscurth P, Bodmer S, Schwerdel C, Fontana A. Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells. Eur J Immunol 1987, 17, 1271-1278.
60. Suzumura A, Mezitis SGE, Gonatas NK, Silberberg DH. MHC antigen expression on bulk isolated macrophage-microglia from newborn mouse brain: Induction of Ia antigen expression by γ-interferon. J Neuroimmunol 1987, 15, 263-278.
61. Panek RB, Benveniste EN. Class IIMHC gene expression in microglia: regulation by the cytokines IFN-γ, TNF-α and TGF-β. J Immunol 1995, 154, 2846-2854.
62. McGeer PL, Kawamata T, Walker DG, Akiyama H, Tooyama I, McGeer E. Microglia in degenerative neurological disease. GLJA 1993, 7, 84-92.
63. Dickson DW, Lee SC, Mattiace LA, Yen S-HC, Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. GLIA 1993, 7, 75-83.
64. Williams K, Ulvestad E, Antel JP. B7/BB-1 antigen expression on adult human microglia studied in vitro and in situ. Eur J Immunol 1994, 24, 3031-3037.
65. De Simone R, Giampaolo A, Giometto B, Gallo P, Levi G, Peschle C, Aloisi F. The costimulatory molecule B7 is expressed on human microglia in culture and in multiple sclerosis acute lesions. J Neuropath Exp Neurol 1995, 54, 175-187.
66. Iglesias BM, Cerase J, Ceracchini C, Levi G, Aloisi F. Analysis of B7-1 and B7-2 costimulatory ligands in cultured mouse microglia: upregulation by interferon-γ and lipopolysaccharide and downregulation by interleukin-10, prostaglandin E2 and cyclic AMP-elevating agents. J Neuroimmunol 1997, 72, 83-93.
67. Winghagen A, Newcombe J, Dangond F, Strand C, Woodroofe MN, Cuzner ML, Hafler DA. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. J Exp Med 1995, 182, 1985-1996.
68. Dangond F, Windhagen A, Groves CJ, Hafler DA. Constitutive expression of costimulatory molecules by human microglia and its relevance to CNS autoimmunity. J Neuroimmunol 1997, 76, 132-138.
69. van Kooten C, Banchereau J. Functions of CD40 on B cells, dendritic cells and other cells. Curr Opin Cell Biol 1997, 9, 330-337.
70. Gerritse K, Laman JD, Noelle RJ, Aruffo A, Ledbetter JA, Boersma WJA, Claassen E. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA 1996, 93, 2499-2504.
71. Grewal I, Foellmer H, Grewal K, Xu J, Hardardottir F, Baron J, Janeway C, Flavell R. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 1996, 273, 1864-1867.
72. Nguyen V, Walker WS, Benveniste EN. Post-transcriptional inhibition of CD40 gene expression in microglia by TGF-β. Eur J Immunol. 1998, 28, 2537-2548.
73. Dhib-Jalbut S, Gogate N, Jiang H, Eisenberg H, Bergey G. Human microglia activate lymphoproliferative responses to recall viral antigens. J Neuroimmunol 1996, 65, 67-73.
74. + T lymphocytes in the central nervous system. Clin Exp Immunol 1994, 98, 313-318.
75. Ford AL, Foulcher E, Lemckert FA, Sedgwick JD. Microglia induce CD4 T lymphocyte final effector function and death. J Exp Med. 1996, 184, 1737-1745.
76. Frei K, Lins H, Schwerdel C, Fontana A. Antigen presentation in the central nervous system: The inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. J Immunol 1994, 152, 2720-2728.
77. Hayashi M, Dorf ME, Abromson-Leeman S. Granulocyte-macrophage colony stimulating factor inhibits class II major histocompatibility complex expression and antigen presentation by microglia. J Neuroimmunol 1993, 48, 23-32.
78. Lee SC, Liu W, Roth P, Dickson DW, Berman JW, Brosnan CF. Macrophage colony-stimulating factor in human fetal astrocytes and microglia: Differential regulation by cytokines and lipopolysaccharide, and modulation of class II MHC on microglia. J Immunol 1993, 150, 594-604.
79. Suzumura A, Sawada M, Itoh Y, Marunouchi T. Interleukin-4 induces proliferation and activation of microglia but suppresses their induction of class II major histocompatibility complex antigen expression. J Neuroimmunol 1994, 53, 209-218.
80. Neumann H, Misgeld T, Matsumuro K, Wekerle H. Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor. Proc Natl Acad Sci USA 1998, 95, 5779-5784.
81. Heese K, Hock C, Otten W. Inflammatory signals induce neurotrophin expression in human microglial cells. J Neurochem 1998, 70, 699-707.
82. Elkabes S, DiCicco-Bloom EM, Black IB. Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function. J Neurosci 1996, 16, 2508-2521.
83. Hayashi M, Luo Y, Laning J. Stricter RM, Dorf M.E. Production and function of monocyte chemoattractant protein-1 and other β-chemokines in murine glial cells. J Neuroimmunol 1995, 60, 143-150.
84. Mizuno T, Sawada M, Marunouchi T, Suzumura A. Production of interleukin-10 by mouse glial cells in culture. Biochem Biophys Res Commun 1994, 205, 1907-1915.
85. Chao CC, Hu S, Sheng WS, Peterson PK. Tumor necrosis factor-alpha production by human fetal microglial cells: regulation by other cytokines. Dev Neurosci 1995, 17, 97-105.
86. Aloisi F, Penna G, Cerase J, Iglesias BM, Adorini L. IL-12 production by central nervous system microglia is inhibited by astrocytes. J Immunol 1997, 159, 1604-1612.
87. Williams K, Dooley N, Ulvestad E, Becher B, Antel JP. IL-10 production by adult human derived microglial cells. Neurochem Int 1996, 29, 55-64.
88. Zajicek JP, Wing M, Scolding NJ, Compston DAS. Interactions between oligodendrocytes and microglia. Brain 1992, 115, 1611-1631.
89. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995, 13, 251-276.
90. Stalder AK, Pagenstecher A, Yu NC, Kincaid C, Chiang C-S, Hobbs MV, Bloom FE, Campbell IL. Lipopolysaccharide-induced IL-12 expression in the central nervous system and cultured astrocytes and microglia. J Immunol 1997, 159, 1344-1351.
91. Torres C, Aránguez I, Rubio N. Expression of interferon-γ receptors on murine oligodendrocytes and its regulation by cytokines and mitogens. Immunology 1995, 86, 250-255.
92. Agresti C, D'Urso D, Levi G. Reversible inhibitory effects of interferon-γ and tumour necrosis factor-α on oligodendroglial lineage cell proliferation and differentiation in vitro. Eur J Neurosci 1996, 8, 1106-1116.
93. Vartanian T, Li Y, Zhao M, Stefansson K. Interferon-γ-induced oligodendrocyte cell death: implications for the pathogenesis of multiple sclerosis. Mol Med 1995, 1, 732-743.
94. Turnley AM, Miller JFAP, Bartlett PF. Regulation of MHC molecules on MBP positive oligodendrocytes in mice by IFN-γ and TNF-α. Neurosci Letters 1991, 123, 45-48.
95. Turnley AM, Morahan G, Okano H, Bernard O, Mikoshiba K, Allison J, Bartlett PF, Miller JFAP. Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature 1991, 353, 566-569.
96. Power C, Kong P-A, Trapp BD. Major histocompatibility complex class I expression in oligodendrocytes induces hypomyelination in transgenic mice. J Neurosci Res 1996, 44, 165-173.
97. Neumann H, Cavalie A, Jenne DE, Wekerle H. Induction of MHC class I genes in neurons. Science 1995, 269, 549-552.
98. Neumann H, Schmidt H, Cavalid A, Jenne D, Wekerle H. Major histocompatibility complex (MHC) class I gene expression in single neurons of the central nervous system: differential regulation by interferon (IFN)-γ and tumor necrosis factor (TNF)-α. J Exp Med 1997, 185, 305-316.
99. Rensing-Ehl A, Malipiero U, Irmler M, Tschopp D, Fontana A. Neurons induced to express major histocompatibility complex class I antigen are killed via the perform and not the Fas (APO- 1/CD95) pathway. Eur J Immunol 1996, 26, 2271-2274.
100. Taga T, Kishimoto T. gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol 1997, 15, 797-819.
101. Gruol DL, Nelson TE. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 1997, 15, 307-339.
102. Modur V, Li Y, Zimmerman GA, Prescott SM, McIntyre TM. Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha. J Clin Invest 1997, 100, 2752-2756.
103. Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P, Faggioni R, Luini W, van Hinsbergh V, Poli V, Ciliberto G, Mantovani A. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity 1997, 6, 315-325.
104. Caldenhoven E, Coffer P, Yuan J, Van De Stolpe A, Horn F, Kruijer W, Van Der Saag PT. Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-γ involves binding of distinct factors to a palindromic response element. J Biol Chem 1994, 269, 21146-21154.
105. Benveniste EN, Tang LP, Law RM. Differential regulation of astrocyte TNF-α expression by the cytokines TGF-β, IL-6 and IL-10. Int J Dev Neurosci 1995, 13, 341-349.
106. Aderka D, Le J, Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 1989, 143, 3517-3523.
107. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994, 83, 113-118.
108. Rodriguez M, Pavelko KD, McKinney CW, Leibowitz JL. Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. J Immunol 1994, 153, 3811-3821.
109. Willenborg DO, Fordham SA, Cowden WB, Ramshaw IA. Cytokines and murine autoimmune encephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand J Immunol 1995, 41, 31-41.
110. Müllberg J, Schooltink H, Stoyan T, Günther M, Graeve L, Buse G, Mackiewicz A, Heinrich PC, Rose-John S. The soluble interleukin-6 receptor is generated by shedding. Eur J Immunol 1993, 23, 473-480.
111. Lust JA, Donovan KA, Kline MP, Greipp PR, Kyle RA, Maihle NJ. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 1992, 4, 96-100.
112. Rose-John S, Heinrich PC. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J 1994, 300, 281-290.
113. Waage A, Halstensen A, Shalaby R, Brandtzaeg P, Kierulf P, Espevik T. Local production of tumor necrosis factor α, interleukin 1, and interleukin 6 in meningococcal meningitis. J Exp Med 1989, 170, 1859-1867.
114. Navikas V, Matusevicius D, Söderström M, Fredrikson S, Kivisäkk P, Ljungdahl Å, Höjeberg B, Link H. Increased interleukin-6 mRNA expression in blood and cerebrospinal fluid mononuclear cells in multiple sclerosis. J Neuroimmunol 1996, 64, 63-69.
115. Maimone D, Annunziata P, Simone IL, Livrea P, Guazzi GC. Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 1993, 47, 55-62.
116. Kossmann T, Hans V, Imhof H-G, Trentz O, Morganti-Kossmann MC. Interleukin-6 released in human cerebrospinal fluid following traumatic brain injury may trigger nerve growth factor production in astrocytes. Brain Res 1996, 713, 143-152.
117. Blum-Degen D, Müller T, Kuhn W, Gerlach M, Przuntek H, Riederer P. Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett 1995, 202, 17-20.
118. März P, Heese K, Hock C, Golombowski S, Müller-Spahn F, Rose-John S, Otten U. Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients. Neurosci Lett 1997, 239, 29-32.
119. Loddick SA, Turnbull AV, Rothwell NJ. Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 1998, 18, 176-179.
120. Frieling JTM, Sauerwein RW, Wijdenes J, Hendriks T, van der Linden CJ. Soluble interleukin 6 receptor in biological fluids from human origin. Cytokine 1994, 6, 376-381.
121. März P, Cheng J-G, Gadient RA, Patterson PH, Stoyan T, Otten U, Rose-John S. Sympathetic neurons can produce and respond to interleukin 6. Proc Natl Acad Sci USA 1998, 95, 3251-3256.
122. Suzumura A, Sawada M, Marunouchi T. Selective induction of interleukin-6 in mouse microglia by granulocyte-macrophage colony-stimulating factor. Brain Res 1996, 713, 192-198.
123. Norris JG, Tang L-P, Sparacio SM, Benveniste EN. Signal transduction pathways mediating astrocyte IL-6 induction by IL-1β and tumor necrosis factor-α. J Immunol 1994, 152, 841-850.
124. Benveniste EN, Sparacio SM, Norris JG, Grenett HE, Fuller GM. Induction and regulation of interleukin-6 gene expression in rat astrocytes. J Neuroimmunol 1990, 30, 201-212.
125. Rubio N, Sierra A. Interleukin-6 production by brain tissue and cultured astrocytes infected with Theiler's murine encephalomyelitis virus. GLIA 1993, 9, 41-47.
126. Frei K, Malipiero UV, Leist TP, Zinkernagel RM, Schwab ME, Fontana A. On the cellular source and function of interleukin-6 produced in the central nervous system in viral diseases. Eur J Immunol 1989, 19, 689-694.
127. Oh J-W, Van Wagoner N, Rose-John S, Benveniste EN. Role of IL-6 and the soluble IL-6 receptor in inhibition of VCAM-1 gene expression. J Immunol 1998, (In press)
128. Tilg H, Dinarello CA, Mier JW. IL-6 and APPS: anti- inflammatory and immunosuppressive mediators. Immunol Today 1997, 18, 428-432.
129. Gadient RA, Otten UH. Interleukin-6 (IL-6) - a molecule with both beneficial and destructive potentials. Progress in Neurobiology 1997, 52, 379-390.
130. Selmaj KW, Farooq M, Norton WT, Raine CS, Brosnan CF. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J Immunol 1990, 144, 129-135.
131. Campbell IL, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MBA, Mucke L. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci USA 1993, 90, 10061-10065.
132. Fattori E, Lazzaro D, Musiani P, Modesti A, Alonzi T, Ciliberto G. IL-6 expression in neurons of transgenic mice causes reactive astrocytosis and increase in ramified microglial cells but no neuronal damage. Eur J Neurosci 1995, 7, 2441-2449.
133. Brett FM, Mizisin AP, Powell HC, campbell IL. Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropath Exp Nenrol 1995, 54, 766-775.
134. Heyser CJ, Masliah E, Samimi A, Campbell IL, Gold LH. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc Natl Acad Sci USA 1997, 94, 1500-1505.
135. Klein MA, Möller JC, Jones LL, Bluethmann H, Kreutzberg GW, Raivich G. Impaired neuroglial activation in interleukin-6 deficient mice. GLIA 1997, 19, 227-233.
136. 1-antichymotrypsin expression in human cortical astrocytes. J Biol Chem 1998, 273, 4112-4118.
137. Watanabe D, Yoshimura R, Khalil M, Yoshida K, Kishimoto T, Taga T, Kiyama H. Characteristic localization of gp130 (the signal transducing receptor component used in common for IL-6/IL-11/CNTF/LIF/OSM) in the rat brain. Eur J Neurosci 1996, 8, 1630-1640.
138. Barres BA, Schmid R, Sendnter M, Raff MC. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993, 118, 283-295.
139. Mayer M, Bhakoo K, Noble M. Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 1994, 120, 143-153.
140. Louis J-C, Magal E, Takayama S, Varon S. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science 1993, 259, 689-692.
141. D'Souza SD, Alinauskas KA, Antel JP. Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury. J Neurosci Res 1996, 43, 289-298.
142. Wu YY, Bradshaw RA. Induction of neurite outgrowth by interleukin-6 is accompanied by activation of Stat3 signaling pathway in a variant PC12 cell (E2) line. J Biol Chem 1996, 271, 13023-13032.
143. Letterio JJ, Roberts AB. Molecule of the month. TGF-β: a critical modulator of immune cell function. Clin Immunol Inununopathol 1997, 84, 244-250.
144. Kallapur S, Shull M, Dopestschman T. Phenotypes of TGFβ knockout mice. In Durum SK, Muegge K, editors, Contemporary Immunology: Cytokine Knockouts. Humana Press, Inc., Totowa, 1998: 335-368.
145. King C, Davies J, Mueller R, Lee M-S, Krahl T, Yeung B, O'Connor E, Sarvetnick N. TGF-β1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity, 1998, 8, 601-613.
146. Weiner HL. Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 1997, 18, 335-343.
147. Strober W, Kelsall B, Fuss I, Marth T, Ludviksson B, Ehrhardt R, Neurath M. Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammation. Immunol Today 1997, 18, 61-64.
148. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994, 265, 1237-1240.
149. Heldin C-H, Miyazono K, ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 1997, 390, 465-471.
150. Hu PP, Datto MB, Wang X-F. Molecular mechanisms of transforming growth factor signaling. Endocrine Rev 1998, 19, 349-363.
151. Beck J, Rondot P, Jullien P, Wietzerbin J, Lawrence DA. TGF-β-like activity produced during regression of exacerbations in multiple sclerosis. Acta Neurol Scand 1991, 84, 452-455.
152. Mokhtarian F, Shi Y, Shirazian D, Morgante L, Miller A, Grob D. Defective production of anti-inflammatory cytokine, TGF-β by T cell lines of patients with active multiple sclerosis. J Immunol 1994, 152, 6003-6010.
153. Correale J, Gilmore W, McMillan M, Li S, McCarthy K, Le T, Weiner LP. Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J Immunol 1995, 154, 2959-2968.
154. Wahl SM, Allen JB, Francis NM. Macrophage- and astrocyte-derived transforming growth factor β as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome. J Exp Med 1991, 173, 981-991.
155. Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-β1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 1996, 98, 70-77.
156. Wyss-Coray T, Masliah E, Mallory M, McConiogue L, Johnson-Wood K, Lin C, Mucke L. Amyloidgenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease. Nature 1997, 389, 603-606.
157. Kim JS, Yoon SS, Kim YH, Ryu JD. Serial measurement of interleukin-6, transforming growth factor-β, and S-100 protein in patients with acute stroke. Stroke 1996, 27, 1553-1557.
158. 1 on scar production in the injured central nervous system of the rat. Eur J Neurosci 1994, 6, 355-363.
159. Kiefer R, Schweitzer T, Jung S, Toyka KV, Hartung H-P. Sequential expression of transforming growth factor-β1 by T cells, macrophages, and microglia in rat spinal cord during autoimmune inflammation. J Neuropathol Exp Neurol 1998, 57, 385-395.
160. Khoury SJ, Hancock WW, Weiner HL. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor β, interleukin 4, and prostaglandin E expression in the brain. J Exp Med 1992, 176, 1355-1364.
161. Racke MK, Cannella B, Albert P, Sporn M, Raine CS, McFarlin DE. Evidence of endogenous regulatory function of transforming growth factor-β1 in experimental allergic encephalomyelitis. Inter. Immunol 1992, 4, 615-620.
162. Issazadeh S, Lorentzen J, Mustafa M, Hojeberg B, Mussener A, Olsson T. Cytokines in relapsing experimental autoimmune encephalomyelitis in da rats: persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-β. J Neuroimmunol 1996, 69, 103-115.
163. Morganti-Kossmann MC, Kossmann T, Brandes ME, Mergenhagen SE, Wahl SM. Autocrine and paracrine regulation of astrocyte function by transforming growth factor-β. J Neuroimmunol 1992, 39, 163-174.
164. da Cunha A, Vitkovic L. Transforming growth factor-beta (TGF-β1) expression and regulation in rat cortical astrocytes. J Neuroimmunol 1992, 36, 157-169.
165. da Cunha A, Jefferson JA, Jackson RW, Vitkovic L. Glial cell-specific mechanisms of TGF-β1 induction by IL-1 in cerebral cortex. J Neuroimmunol 1993, 42, 71-86.
166. Panek RB, Lee Y-J, Benveniste EN. TGF-β suppression of IFN-γ induced class II MHC gene expression does not involve inhibition of phosphorylation of JAK1, JAK2 or STATIα or modification of IFNEX expression. J Immunol 1995, 154, 610-619.
167. Barnum SR, Jones JL. Transforming growth factor-β inhibits inflammatory cytokine-induced C3 gene expression in astrocytes. J Immunol 1994, 152, 765-773.
168. Shrikant P, Lee SJ, Kalvakalanu I, Ransohoff RM, Benveniste EN. Stimulus-specific inhibition of ICAM-1 gene expression by TGF-β. J Immunol 1996, 157, 892-900.
169. Oh J-W, Schwiebert LM, Benveniste EN. Expression of CC and CXC chemokines by human astrocytes. J Neurovirol, 1998, (In press).
170. Hurwitz AA, Lyman WD, Berman JW. Tumor necrosis factor α and transforming growth factor β upregulate astrocyte expression of monocyte chemoattractant protein-1. J Neuroimmunol 1995, 57, 193-198.
171. Benveniste EN, Kwon JB, Chung WJ, Sampson J, Pandya K, Tang L-P. Differential modulation of astrocyte cytokine gene expression by TGF-β. J Immunol 1994, 153, 5210-5221.
172. Silberstein FC, De Simone R, Levi G, Aloisi F. Cytokine-regulated expression of platelet-derived growth factor gene and protein in cultured human astrocytes. J Neurochem 1996, 66, 1409-1417.
173. Lindholm D, Castren E, Kiefer R, Zafra F, Thoenen H. Transforming growth factor-β1 in the rat brain: increase after injury and inhibition of astrocyte proliferation. J Cell Biol 1992, 117, 395-400.
174. Hunter KE, Sporn MB, Davies AM. Transforming growth factor-βs inhibit mitogen-stimulated proliferation of astrocytes. GLIA 1993, 7, 203-211.
175. Baghdassarian D, Toru-Delbauffe D, Gavaret JM, Pierre M. Effects of transforming growth factor-β1 on the extracellular matrix and cytoskeleton of cultured astrocytes. GLIA 1993, 7, 193-202.
176. 1 null mouse phenotype. Proc Natl Acad Sci USA 1993, 90, 9944-9948.
177. Diebold RJ, Eis MJ, Yin M, Ormsby I, Boivin GP, Darrow BJ, Saffitz JE, Doetschman T. Early-onset multifocal inflammation in the transforming growth factor β1-null mouse is lymphocyte mediated. Proc Natl Acad Sci USA 1995, 92, 12215-12219.
178. Fabry Z, Topham DJ, Fee D, Herlein J, Carlino JA, Hart MN, Sriram S. TGF-β2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in vivo. J Immunol 1995, 155, 325-332.
179. Racke MK, Jalbut SD, Cannella B, Albert PS, Raine CS, McFarlin DE. Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-β1. J Immunol 1991, 146, 3012-3017.
180. Santambrogio L, Hochwald GM, Saxena B, Leu C-H, Martz JE, Carlino JA, Ruddle NH, Palladino MA, Gold LI, Thorbecke GJ. Studies on the mechanisms by which transforming growth factor (TGF-β) protects against allergic encephalomyelitis: Antagonism between TGF-β and tumor necrosis factor. J Immunol 1993, 151, 1116-1127.
181. Galbreath E, Kim S-J, Park K, Brenner M, Messing A. Overexpression of TGF-β1 in the central nervous system of transgenic mice results in hydocephalus. J Neuropath Exp Neurol 1995, 54, 339-349.
182. Wyss-Coray T, Feng L, Masliah E, Ruppe MD, Lee HS, Toggas SM, Rockenstein EM, Mucke L. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-β1. Amer J Pathol 1995, 147, 53-67.
183. Wyss-Coray T, Borrow P, Brooker MJ, Mucke L. Astroglial overproduction of TGF-β1 enhances inflammatory central nervous system disease in transgenic mice. J Neuroimmunol 1997, 77, 45-50.
184. Böttinger EP, Letterio JJ, Roberts AB. Biology of TGF-β in knockout and transgenic mouse models. Kidney Int 1997, 51, 1355-1360.
185. Suzumura A, Sawada M, Yamamoto H, Marunouchi T. Transforming growth factor suppresses activation and proliferation of microglia in vitro. J Immunol 1993, 151, 2150-2158.
186. Lodge PA, Sriram S. Regulation of microglial activation by TGF-β, IL-10, and CSF-1. J Leukoc Biol 1996, 60, 502-508.
187. McKinnon RD, Piras G, Ida JA, Jr, Dubois-Dalcq M. A role for TGF-β in oligodendrocyte differentiation. J Cell Biol 1993, 121, 1397-1407.
188. + toxicity. EMBO J 1995, 14, 736-742.
189. Chalazonitis A, Kalberg J, Twardzik DR, Morrison RS, Kessler JA. Transforming growth factor β has neurotrophic actions on sensory neurons in vitro and is synergistic with nerve growth factor. Develop Biol 1992, 152, 121-132.
190. Martinou J-C, Le Van Thai A, Valette A, Weber MJ. Transforming growth factor β1 is a potent survival factor for rat embryo motoneurons in culture. Dev Brain Res 1990, 52, 175-181.
191. Ishihara A, Saito H, Abe K. Transforming growth factor-β1 and -β2 promote neurite sprouting and elongation of cultured rat hippocampal neurons. Brain Res 1994, 639, 21-25.
192. + homeostasis and rescues cortical neurons from apoptotic death. J Neurosci Res 1997, 49, 600-607.
193. Henrich-Noack P, Prehn JHM, Krieglstein J. Neuroprotective effects of TGF-β1. J Neural Transm (Suppl) 1994, 43, 33-45.
194. Prehn JHM, Backhaub C, Krieglstein J. Transforming growth factor-β1 prevents glutamate neurotoxicity in rat neocortical cultures and protects mouse from ischemic injury in vivo. Cereb Blood Flow Metab 1993, 13, 521-525.
195. de Luca A, Weller M, Fontana A. TGF-β-induced apoptosis of cerebellar granule neurons is prevented by depolarization. J Neurosci 1996, 16, 4174-4185.
196. Mathisen PM, Tuohy VK. Gene therapy in the treatment of autoimmune disease. Immunol Today 1998, 19, 103-105.
197. Shaw MK, Lorens JB., Dhawan A, DalCanto R, Tse HY, Tran AB, Bonpane C, Eswaran SL, Brocke S, Sarvetnick N, Steinman L, Nolan GP, Fathman CG. Local delivery of interleukin 4 by retrovirus-transduced T lymphocytes ameliorates experimental autoimmune encephalomyelitis. J Exp Med 1997, 185, 1711-1714.
198. Mathisen PM., Yu M, Johnson JM, Drazba JA, Tuohy VK. Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J Exp Med 1997, 186, 159-164.
199. Norris JG, Benveniste EN. Interleukin-6 production by astrocytes: Induction by the neurotransmitter norepinephrine. J Neuroimmunol 1993, 45, 137-146.